SCHEMBL6058749

SCHEMBL6058749

CC(C)(C)OC(=O)N1CCC(CC(CSCc2ccccc2)C(=O)O)CC1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.52
PKM P14618 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
GAA P10253 1/20 0.52
THRB P10828 1/20 0.52
GPR119 Q8TDV5 3/20 0.49
STS P08842 1/20 0.49
YAP1 P46937 3/20 0.49
KEAP1 Q14145 1/20 0.45
NFE2L2 Q16236 1/20 0.45
JAK2 O60674 1/20 0.45
JAK1 P23458 1/20 0.45
PPARG P37231 1/20 0.44
PPARA Q07869 1/20 0.44
TGFBR1 P36897 1/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
LMNA P02545 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7872006 0.84 KDM4E (0.58) KDM4EPKMSMN1; SMN2GAATHRB
SCHEMBL5574062 0.81 KDM4E (0.51) KDM4EPKMSMN1; SMN2THRBGPR119
SCHEMBL8644404 0.80 KDM4E (0.53) KDM4EPKMSMN1; SMN2GAATHRB
SCHEMBL3170462 0.78 KDM4E (0.54) KDM4EPKMSMN1; SMN2GPR119STS
SCHEMBL3123967 0.78 GAA (0.60) KDM4EPKMSMN1; SMN2GAATHRB
SCHEMBL7141623 0.78 KDM4E (0.48) KDM4EPKMSMN1; SMN2GPR119YAP1
SCHEMBL3923737 0.78 KDM4E (0.64) KDM4EPKMGPR119STSLMNA
SCHEMBL5417967 0.78 ATM (0.48) SMN1; SMN2NPC1RAB9A
SCHEMBL1912705 0.77 KDM4E (0.62) KDM4EPKMSMN1; SMN2GAATHRB
SCHEMBL6060188 0.77 CPN1 (0.49) KDM4EPKMSMN1; SMN2GPR119YAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7071175-B1 Pyridine mercapto carboxylic acids as carboxypeptidase U inhibitors ASTRAZENECA AB (SE) 2006-07-04 US disclosed
EP-1180098-A1 NEW COMPOUNDS AstraZeneca AB (SE) 2002-02-20 EP disclosed
WO-2000066557-A1 NEW COMPOUNDS ASTRAZENECA AB (SE) 2000-11-09 WO disclosed